光子高级剂量计算算法时代PTV均匀性目标:桥接鲁棒性和基于PTV的规划

IF 4.9 1区 医学 Q1 ONCOLOGY
Diego Jurado-Bruggeman , Agnes Angerud , Albin Fredriksson , Carles Muñoz-Montplet
{"title":"光子高级剂量计算算法时代PTV均匀性目标:桥接鲁棒性和基于PTV的规划","authors":"Diego Jurado-Bruggeman ,&nbsp;Agnes Angerud ,&nbsp;Albin Fredriksson ,&nbsp;Carles Muñoz-Montplet","doi":"10.1016/j.radonc.2025.110878","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>The planning target volume (PTV) homogeneity objective was developed for previous-generation dose calculation algorithms. Advanced algorithms report doses to medium-in-medium (<em>D</em><sub>m,m</sub>) and their values depend on the medium considered, breaking the link between uniform irradiation and dose homogeneity. This work revises the PTV homogeneity objective when high-density heterogeneities are involved. We evaluated robust against PTV-based planning, and a dose reporting method that removes composition dependencies to express doses to muscle in muscle-like medium (<em>D</em><sub>muscle,muscle*</sub>).</div></div><div><h3>Methods</h3><div>Four cases featuring bone or metal within the PTV were selected and planned in RayStation with Monte Carlo. Three plans were created for each case: robust optimization for <em>D</em><sub>m,m</sub> (Robust-<em>D</em><sub>m,m</sub>), and PTV-based optimization for <em>D</em><sub>m,m</sub> (PTV-<em>D</em><sub>m,m</sub>) and <em>D</em><sub>muscle,muscle*</sub> (PTV-<em>D</em><sub>muscle,muscle*</sub>). The plans were reported in <em>D</em><sub>m,m</sub> and <em>D</em><sub>muscle,muscle*</sub>, and their dosimetric parameters, robustness, complexities, and optimization times were assessed.</div></div><div><h3>Results</h3><div>Robust-<em>D</em><sub>m,m</sub> and PTV-<em>D</em><sub>muscle,muscle*</sub> plans presented similar <em>D</em><sub>m,m</sub> distributions with inhomogeneous PTV doses due to cold spots in high-density regions. PTV-<em>D</em><sub>m,m</sub> plans achieved homogeneous PTV doses but required local fluence compensations that impaired robustness, with significant hot spots, and increased complexity. Robust optimization was 7 to 11 times slower. Reporting in <em>D</em><sub>muscle,muscle*</sub> restored consistency between PTV-based and robust evaluations.</div></div><div><h3>Conclusions</h3><div>Robust optimization proves that PTV homogeneity should not be prioritized when advanced algorithms reporting <em>D</em><sub>m,m</sub> are used with high-density heterogeneities. PTV-<em>D</em><sub>muscle,muscle*</sub> optimization offers a practical alternative for maintaining PTV-based planning and the PTV homogeneity objective while ensuring consistency with robust optimization. <em>D</em><sub>muscle,muscle*</sub> reporting simplifies plan evaluation and aligns with clinical practice, facilitating decision-making in treatment planning.</div></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":"207 ","pages":"Article 110878"},"PeriodicalIF":4.9000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"On the PTV homogeneity objective in the era of photon advanced dose calculation algorithms: Bridging robust and PTV-based planning\",\"authors\":\"Diego Jurado-Bruggeman ,&nbsp;Agnes Angerud ,&nbsp;Albin Fredriksson ,&nbsp;Carles Muñoz-Montplet\",\"doi\":\"10.1016/j.radonc.2025.110878\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><div>The planning target volume (PTV) homogeneity objective was developed for previous-generation dose calculation algorithms. Advanced algorithms report doses to medium-in-medium (<em>D</em><sub>m,m</sub>) and their values depend on the medium considered, breaking the link between uniform irradiation and dose homogeneity. This work revises the PTV homogeneity objective when high-density heterogeneities are involved. We evaluated robust against PTV-based planning, and a dose reporting method that removes composition dependencies to express doses to muscle in muscle-like medium (<em>D</em><sub>muscle,muscle*</sub>).</div></div><div><h3>Methods</h3><div>Four cases featuring bone or metal within the PTV were selected and planned in RayStation with Monte Carlo. Three plans were created for each case: robust optimization for <em>D</em><sub>m,m</sub> (Robust-<em>D</em><sub>m,m</sub>), and PTV-based optimization for <em>D</em><sub>m,m</sub> (PTV-<em>D</em><sub>m,m</sub>) and <em>D</em><sub>muscle,muscle*</sub> (PTV-<em>D</em><sub>muscle,muscle*</sub>). The plans were reported in <em>D</em><sub>m,m</sub> and <em>D</em><sub>muscle,muscle*</sub>, and their dosimetric parameters, robustness, complexities, and optimization times were assessed.</div></div><div><h3>Results</h3><div>Robust-<em>D</em><sub>m,m</sub> and PTV-<em>D</em><sub>muscle,muscle*</sub> plans presented similar <em>D</em><sub>m,m</sub> distributions with inhomogeneous PTV doses due to cold spots in high-density regions. PTV-<em>D</em><sub>m,m</sub> plans achieved homogeneous PTV doses but required local fluence compensations that impaired robustness, with significant hot spots, and increased complexity. Robust optimization was 7 to 11 times slower. Reporting in <em>D</em><sub>muscle,muscle*</sub> restored consistency between PTV-based and robust evaluations.</div></div><div><h3>Conclusions</h3><div>Robust optimization proves that PTV homogeneity should not be prioritized when advanced algorithms reporting <em>D</em><sub>m,m</sub> are used with high-density heterogeneities. PTV-<em>D</em><sub>muscle,muscle*</sub> optimization offers a practical alternative for maintaining PTV-based planning and the PTV homogeneity objective while ensuring consistency with robust optimization. <em>D</em><sub>muscle,muscle*</sub> reporting simplifies plan evaluation and aligns with clinical practice, facilitating decision-making in treatment planning.</div></div>\",\"PeriodicalId\":21041,\"journal\":{\"name\":\"Radiotherapy and Oncology\",\"volume\":\"207 \",\"pages\":\"Article 110878\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-04-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Radiotherapy and Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0167814025001732\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167814025001732","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的为上一代剂量计算算法建立计划靶体积(PTV)均匀性目标。先进的算法报告中中剂量(Dm,m)及其值取决于所考虑的介质,从而打破了均匀照射与剂量均匀性之间的联系。当涉及到高密度的非均质性时,本工作修正了PTV均匀性目标。我们对基于pvt的计划和剂量报告方法进行了稳健评估,该方法消除了成分依赖性,以表达肌肉样培养基中肌肉的剂量(Dmuscle,muscle*)。方法选择4例PTV内有骨或金属的病例,在蒙特卡洛射线工作站中进行规划。针对每种情况创建了三个方案:Dm,m的鲁棒优化(robust -Dm,m)和Dm,m (PTV-Dm,m)和Dmuscle,muscle* (PTV-Dmuscle,muscle*)的基于ptv的优化。在Dm、m和Dmuscle、muscle*中报道了这些方案,并评估了它们的剂量学参数、稳健性、复杂性和优化时间。结果robust -Dm,m和PTV- dmuscle,muscle*图Dm,m分布相似,但由于高密度区存在冷点,PTV剂量不均匀。PTV- dm,m计划实现了均匀的PTV剂量,但需要局部影响补偿,这损害了鲁棒性,具有显著的热点,并增加了复杂性。鲁棒优化速度要慢7到11倍。在Dmuscle报告中,muscle*恢复了基于ptv和稳健评估之间的一致性。结论鲁棒优化证明,当报告Dm、m的高级算法用于高密度异构性时,不应优先考虑PTV均匀性。PTV- dmuscle,muscle*优化为维护PTV为基础的规划和PTV同质性目标提供了一个实用的替代方案,同时确保与鲁棒优化的一致性。Dmuscle,muscle*报告简化了计划评估,并与临床实践保持一致,促进了治疗计划的决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
On the PTV homogeneity objective in the era of photon advanced dose calculation algorithms: Bridging robust and PTV-based planning

Aim

The planning target volume (PTV) homogeneity objective was developed for previous-generation dose calculation algorithms. Advanced algorithms report doses to medium-in-medium (Dm,m) and their values depend on the medium considered, breaking the link between uniform irradiation and dose homogeneity. This work revises the PTV homogeneity objective when high-density heterogeneities are involved. We evaluated robust against PTV-based planning, and a dose reporting method that removes composition dependencies to express doses to muscle in muscle-like medium (Dmuscle,muscle*).

Methods

Four cases featuring bone or metal within the PTV were selected and planned in RayStation with Monte Carlo. Three plans were created for each case: robust optimization for Dm,m (Robust-Dm,m), and PTV-based optimization for Dm,m (PTV-Dm,m) and Dmuscle,muscle* (PTV-Dmuscle,muscle*). The plans were reported in Dm,m and Dmuscle,muscle*, and their dosimetric parameters, robustness, complexities, and optimization times were assessed.

Results

Robust-Dm,m and PTV-Dmuscle,muscle* plans presented similar Dm,m distributions with inhomogeneous PTV doses due to cold spots in high-density regions. PTV-Dm,m plans achieved homogeneous PTV doses but required local fluence compensations that impaired robustness, with significant hot spots, and increased complexity. Robust optimization was 7 to 11 times slower. Reporting in Dmuscle,muscle* restored consistency between PTV-based and robust evaluations.

Conclusions

Robust optimization proves that PTV homogeneity should not be prioritized when advanced algorithms reporting Dm,m are used with high-density heterogeneities. PTV-Dmuscle,muscle* optimization offers a practical alternative for maintaining PTV-based planning and the PTV homogeneity objective while ensuring consistency with robust optimization. Dmuscle,muscle* reporting simplifies plan evaluation and aligns with clinical practice, facilitating decision-making in treatment planning.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Radiotherapy and Oncology
Radiotherapy and Oncology 医学-核医学
CiteScore
10.30
自引率
10.50%
发文量
2445
审稿时长
45 days
期刊介绍: Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信